Acknowledgement
Supported by : 전북농업기술원
References
- Georg, P., Ludvik, B. Lipids and diabetes. J. Clin. Basic. Cardiol. 3: 159-162, 2000.
- International Diabetes Federation. Diabetes Atlas, 2nd ed, 2003 Available at: www.eatlas.idf.org (accessed on July 12, 2008).
- Yoon, K.H., Lee, J.H., Kim, J.W., Cho, J.H., Choi, Y.H., Ko, S.H., Zimmet, P., Son, H.Y. Epidemic obesity and type 2 diabetes in Asia. Lancet. 11: 1681-1688, 2006.
- Tay, S.S., Mc Cormack, A., Rose, M.L. Effect of cognate human CD4+ Tcell and endothelial cell interactions upon chemokine production. Transplantatio.n 78(7):987-994, 2004. https://doi.org/10.1097/01.TP.0000137205.26405.40
- Uze, G., Pachman, L.M. Cytokines in juvenile dermatomyositis pathophysiology: potential and challenge. Curr. Opin. Rheumatol. 15(6):691-697, 2003. https://doi.org/10.1097/00002281-200311000-00003
- Frostegard, J., Wu, R., Haegerstrand, A., patarroyo, M., Lefver,, A.K. Mononuclear leukocytes exposed to oxidized low density lipoprotein secrete a factor that stimulates endothelial cells to express adhesion molecules. Atherosclerosis. 103: 213-219, 1993. https://doi.org/10.1016/0021-9150(93)90264-U
- Mes, Bouhle., M.A., Staels, B., Chinetti-Gbaguid, G. Peroxisome proliferator-activated receptors-from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease. J. Intern. Med. 263(1):28-42, 2008.
- Li, J.J., Zhu, C.G., Yu, B., Liu, Y.X., Yu, M.Y. The role of inflammation in coronary artery calcification. Agening. Res. Rev. 6(4):263-270, 2007. https://doi.org/10.1016/j.arr.2007.09.001
- Matteoni, C.A., Younossi, Z.M., Gramlich, T., Boparai, N., Liu, Y.C., Mc, Cullough, A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 116: 1413-1419, 1999. https://doi.org/10.1016/S0016-5085(99)70506-8
- Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Rizzetto, M. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 123: 134-140, 2002. https://doi.org/10.1053/gast.2002.34168
- Marrero, J.A., Fontana, R.J., Su, G.L., Conjeevaram, H.S., Emick, D.M., Lok, A.S. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 36: 1349-1354, 2002. https://doi.org/10.1002/hep.1840360609
- Jun, D.W. Non-alcoholic fatty liver disease. Korean J. Hepatol. 17: S332-S336, 2011.
- Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., Rizzetto, M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 37: 917-923, 2003. https://doi.org/10.1053/jhep.2003.50161
- Hong, M.H., Lim, H.K., Park, J.E., Jun, N.J., Lee, Y.J., Cho, M.J., Kim, S.M. The Antihypertensive and Vasodilating Effects of Adventitious Root Extracts of Wild Ginseng. J. Korean. Soc. Appl. Biol. Chem. 51: 102-107, 2008. https://doi.org/10.3839/jabc.2008.017
- Mizuno, M., Yamada, J., Terai, H., Kozukue, N., Lee, Y.S., Tsuchide, H. Differences in immunomodulating effects between wild and cultured Panax ginseng. Biochem. Biophys. Res. Commun. 200: 1672-1678, 1994. https://doi.org/10.1006/bbrc.1994.1644
- Kwon, K.R., Park, W.P., Kang, W.M., Jeon, E.Y., Jang, J.H. Identification and analysis of differentially expressed genes in mountain cultivated ginseng and mountain wild ginseng. J. Acupunct. Meridian. Stud. 4: 123-128, 2011. https://doi.org/10.1016/S2005-2901(11)60018-6
- Liu, C.X., Xiao, P.G. Recent advances on ginseng research in China. J. Ethnopharmacol. 36: 27-38, 1992. https://doi.org/10.1016/0378-8741(92)90057-X
- Kitts, D., Hu, C. Efficacy and safety of ginseng. Public. Health. Nutr. 3: 473-485, 2000.
- Enkhmaa, B., Shiwaku, K., Katsube, T., Kitajima, K., Anuurad, E., Yamasaki, M., Yamane, Y. Mulberry (Morus alba L.) leaves and their major flavonol quercetin 3-(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice. J. Nutr. 135: 729-734, 2005. https://doi.org/10.1093/jn/135.4.729
- Miyahara, C., Miyazawa, M., Satoh, S., Sakai, A., Mizusaki, S. Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats. J. Nutr. Sci. Vitaminol. 50: 161-164, 2004. https://doi.org/10.3177/jnsv.50.161
- Lee, Y.J., Choi, D.H., Kim, E.J., Kim, H.Y., Kwon, T.O., Kang, D.G., Lee, H.S. Hypotensive, hypolipidemic, and vascular protective effects of Morus alba L. in rats fed an atherogenic diet. Am. J. Chin. Med. 39: 39-52, 2011. https://doi.org/10.1142/S0192415X11008634
- Park, S.H., Jeon, W.K., Kim, S.H., Kim, H.J., Park, D.I., Cho, Y.K., Sung, I.K., Sohn, C.I., Keum, D.K., Kim, B.I. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 21: 138-143, 2006. https://doi.org/10.1111/j.1440-1746.2005.04086.x
- Elliott, S.S., Keim, N.L., Stern, J.S., Teff, K., Havel, P.J. Fructose, weight gain, and the insulin resistance syndrome. Am. J. Clin. Nutr. 76: 911-922, 2002. https://doi.org/10.1093/ajcn/76.5.911
- Hwang, I.S., Ho, H., Hoffman, B.B., Reaven, G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 10: 512-516, 1987. https://doi.org/10.1161/01.HYP.10.5.512
- Sanchez-Lozada, L.G., Tapia, E., Jimenez, A., Bautista, P., Cristobal, M., Nepomuceno, T., Soto, V., Avila-Casado, C., Nakagawa, T., Johnson, R.J, Herrera-Acosta, J., Franco, M. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am. J. Physiol. Renal. Physiol. 292: 423-429, 2007.
- Feingold, K.R., Grunfeld, C. Role of cytokines in inducing hyperlipidemia. Diabetes. 41: 97-101, 1992. https://doi.org/10.2337/diab.41.2.S97
- Stenvinkel, P., Heimburger, O., Jogestrand, T. Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: Association with Chlamydia pneumoniae seropositivity. Am. J. Kidney. Dis. 39: 274-282, 2002. https://doi.org/10.1053/ajkd.2002.30546
- Duprez, D.A., Somasundaram, P.E., Sigurdsson, G., Hoke, L., Florea, N., Cohn, J.N. Relationship between Creactive protein and arterial stiffness in an asymptomatic population. J. Hum. Hypertens. 19: 515-519, 2005. https://doi.org/10.1038/sj.jhh.1001860
- Hommels, M.J, van der Ven A.J.A.M., Kroon, A.A., Kessels, A.G.H., Van Dieijen-Visser, M.P., Van Engelshoven, J.A.M., Bruggeman, C.A., De Leeuw, P.W. C-reactive protein, atherosclerosis and kidney function in hypertensive patients. J. Hum. Hypertens. 19: 521-526, 2005. https://doi.org/10.1038/sj.jhh.1001878
- Quagliaro, L., Piconi, L., Assaloni, R., Da Ros, R., Maier, A., Zuodar, G., Schreyer, S.A., Vick, C., Lystig, T.C., Mystkowski, P., LeBoeuf, R.C. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am. J. Physiol. Endocrinol. Metab. 282: 207-214, 2002. https://doi.org/10.1152/ajpendo.2002.282.1.E207
- Diehl, A.M. Nonalcoholic steatohepatitis. Semin. liver. dis. 19: 220-229, 1999.
- Akyuz, F., Demir, K., Ozdil, S., Aksoy, N., Poturoglu, S., Ibrisim, D., Kaymakoglu, S., Besisik, F., Boztas, G., Cakaloglu, Y., Mungan, Z., Cevikbas, U., Okten, A. The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease. Dig. Dis. Sci. 52:2359-2367, 2007. https://doi.org/10.1007/s10620-006-9145-x
- Neuschwander-Tetri, B.A., Brunt, E.M., Wehmeier, K.R., Oliver, D., Bacon, B.R. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology. 38: 1008-1017, 2003. https://doi.org/10.1002/hep.1840380427
- Belfort, R., Harrison, S.A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., Berria, R., Ma, J.Z., Dwivedi, S., Havranek, R., Fincke, C., DeFronzo, R., Bannayan, G.A., Schenker, S., Cusi, K. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355: 2297-2307, 2006. https://doi.org/10.1056/NEJMoa060326
- Promrat, K., Lutchman, G., Uwaifo, G.I., Freedman, R.J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., Liang, T.J., Yanovski, J.A., Kleiner, D.E., Hoofnagle, J.H. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology. 39: 188-196, 2004. https://doi.org/10.1002/hep.20012
- Fortez, M., Ancellin, N., Andreelli, F., Saintillan, Y., Grondin, P., Kahn, A., Thorens, B., Vaulont, S., Viollet, B. Short-term overexpression of a constitutively active form of AMPK-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes. 54: 1331-1339, 2005. https://doi.org/10.2337/diabetes.54.5.1331
- Nielsen, S., Guo, Z., Johnson, C.M., Hensrud, D.D., Jensen, M.D. Splanchnic lipolysis in human obesity. J. Clin. Invest. 113: 1582-1588, 2004. https://doi.org/10.1172/JCI21047
- Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114: 1752-1761, 2004. https://doi.org/10.1172/JCI21625